Fractalkine receptor is expressed in mature ovarian teratomas and required for epidermal lineage differentiation

BACKGROUND: The goal of this study was to determine a predominant cell type expressing fractalkine receptor (CX(3)CR1) in mature ovarian teratomas and to establish functional significance of its expression in cell differentiation. METHODS: Specimens of ovarian teratoma and human fetal tissues were analyzed by immunohistochemistry for CX(3)CR1expression. Ovarian teratocarcinoma cell line PA-1 was used as a model for cell differentiation. RESULTS: We found that the majority of the specimens contained CX(3)CR1-positive cells of epidermal lineage. Skin keratinocytes in fetal tissues were also CX(3)CR1- positive. PA-1 cells with downregulated CX(3)CR1 failed to express a skin keratinocyte marker cytokeratin 14 when cultured on Matrigel in the presence of a morphogen, bone morphogenic protein 4 (BMP-4), as compared to those expressing scrambled shRNA. CONCLUSIONS: Here we demonstrate that CX(3)CR1 is expressed in both normally (fetal skin) and abnormally (ovarian teratoma) differentiated keratinocytes and is required for cell differentiation into epidermal lineage.